Annual report
4028.TEDINET S100W4FV
Period2024-04-01 → 2025-03-31
Filed2025-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amended by S100WKV8 (2025-08-22).
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥145.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥138.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥131.2bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥111.0bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥101.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥10.5bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥11.5bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥11.4bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥14.8bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥10.3bn | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.3bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.9bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥10.8bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥9.5bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥8.4bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥8.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.9bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥11.7bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.4bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥8.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥8.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥225.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥224.3bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥201.9bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥185.8bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥180.0bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥110.6bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥118.2bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥114.4bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥106.1bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥97.4bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥91.9bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥79.5bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥24.9bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥20.0bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥24.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥20.0bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥17.7bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥27.1bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥25.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥18.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥2.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥6.0bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥16.5bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥11.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥7.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.0bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.3bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥2.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥11.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.0bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥11.6bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥219.98 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥209.27 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥175.75 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥292.58 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥84.41 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,986.82 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,776.83 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,554.54 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,299.42 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,990.03 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 50.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.3% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.3% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.5% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.2% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.6% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.9% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.6% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.3% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,807 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 1,813 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 1,768 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 1,750 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 1,743 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥117.9bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥109.1bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥110.5bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥89.1bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥83.2bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥6.8bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥8.6bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥8.3bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥13.0bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥9.8bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.7bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.0bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥7.7bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥7.8bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥6.5bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥6.0bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥7.6bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥6.9bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥3.8bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥192.0bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥192.7bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥172.6bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥159.0bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥155.2bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥103.4bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥108.0bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥88.5bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥84.6bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥79.8bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥75.6bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥68.7bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥16.7bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥13.3bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥171.11 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥156.94 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥192.84 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.15 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥95.88 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥85 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥42 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥36 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,314.49 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,216.1 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,091.59 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,891.21 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,719.42 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 46.1% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.9% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.2% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.5% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.6% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.8% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.5% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.7% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 40,383,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,383,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,383,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,383,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,383,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,139 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 1,146 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 1,146 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 1,144 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 1,149 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 71
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | capex | 2024-04-01 → 2025-03-31 | ¥49m |
| Otherother segments | depreciation | 2024-04-01 → 2025-03-31 | ¥46m |
| Otherother segments | employees | at 2025-03-31 | 127 pure |
| Otherother segments | revenue | 2024-04-01 → 2025-03-31 | ¥8.5bn |
| Otherother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥4.2bn |
| Otherother segments | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥4.4bn |
| Otherother segments | segment assets | at 2025-03-31 | ¥4.5bn |
| Otherother segments | segment profit | 2024-04-01 → 2025-03-31 | ¥752m |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥507m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥571m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥4.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥4.4bn |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥24.7bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥4.3bn |
| Inorganic Chemistryreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥5.6bn |
| Inorganic Chemistryreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥4.0bn |
| Inorganic Chemistryreportable segment | employees | at 2025-03-31 | 989 pure |
| Inorganic Chemistryreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥73.2bn |
| Inorganic Chemistryreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥73.2bn |
| Inorganic Chemistryreportable segment | segment assets | at 2025-03-31 | ¥102.0bn |
| Inorganic Chemistryreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.6bn |
| Organic Chemistryreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥4.3bn |
| Organic Chemistryreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥973m |
| Organic Chemistryreportable segment | employees | at 2025-03-31 | 586 pure |
| Organic Chemistryreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥67.8bn |
| Organic Chemistryreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥67.8bn |
| Organic Chemistryreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥0 |
| Organic Chemistryreportable segment | segment assets | at 2025-03-31 | ¥93.8bn |
| Organic Chemistryreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥12.4bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥10.0bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥5.0bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥149.6bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥145.2bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥4.4bn |
| —segment total | segment assets | at 2025-03-31 | ¥200.4bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥14.8bn |
| Otherother segments | capex | 2023-04-01 → 2024-03-31 | ¥9m |
| Otherother segments | depreciation | 2023-04-01 → 2024-03-31 | ¥49m |
| Otherother segments | revenue | 2023-04-01 → 2024-03-31 | ¥7.1bn |
| Otherother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥3.2bn |
| Otherother segments | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥3.9bn |
| Otherother segments | segment assets | at 2024-03-31 | ¥4.8bn |
| Otherother segments | segment profit | 2023-04-01 → 2024-03-31 | ¥291m |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥900m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥211m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2024-03-31 | −¥3.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2024-03-31 | −¥3.9bn |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥22.2bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥3.4bn |
| Inorganic Chemistryreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥7.8bn |
| Inorganic Chemistryreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥4.0bn |
| Inorganic Chemistryreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥68.0bn |
| Inorganic Chemistryreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥68.0bn |
| Inorganic Chemistryreportable segment | segment assets | at 2024-03-31 | ¥106.0bn |
| Inorganic Chemistryreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥3.3bn |
| Organic Chemistryreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥987m |
| Organic Chemistryreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥957m |
| Organic Chemistryreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥67.2bn |
| Organic Chemistryreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥67.2bn |
| Organic Chemistryreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥0 |
| Organic Chemistryreportable segment | segment assets | at 2024-03-31 | ¥91.2bn |
| Organic Chemistryreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥11.3bn |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥8.7bn |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥5.0bn |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥142.3bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥138.5bn |
| —segment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥3.9bn |
| —segment total | segment assets | at 2024-03-31 | ¥202.1bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥14.9bn |
| Inorganic Chemistryreportable segment | employees | at 2025-03-31 | 650 pure |
| Organic Chemistryreportable segment | employees | at 2025-03-31 | 384 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,821
| Item | Context | Value | Unit |
|---|---|---|---|
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)無(注２) | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)カネコ種苗株式会社 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)株式会社三十三フィナンシャルグループ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)無(注２) | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)日本農薬株式会社 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)菊水化学工業株式会社 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row9Member | Original text (Japanese)日本トランスシティ株式会社 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row9Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row9Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row10Member | Original text (Japanese)高圧ガス工業株式会社 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row10Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row10Member | Original text (Japanese)無(注２) | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row11Member | Original text (Japanese)太陽誘電株式会社 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row11Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row11Member | Original text (Japanese)無 | |
| Footnotes specified investment shares held for purposes other than pure investment reporting company (text) | CurrentYearInstant_Row1Member | Text · Plus | |
| Footnotes specified investment shares held for purposes other than pure investment reporting company (text) | CurrentYearInstant_Row2Member | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that financial statements have been prepared in accordance with special provision financial information | CurrentYearDuration | Original text (Japanese)また、当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しております。 | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Consolidated balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes uncertainties of entitys ability to continue as going concern consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies for preparation of consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Number of consolidated subsidiaries and names of major consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Changes in scope of consolidation (text) | CurrentYearDuration | Text · Plus | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and associates and reasons for not being accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Disclosure about fiscal years etc of consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Disclosure of accounting policies (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in presentation consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding presentation of accumulated impairment loss (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding pledged assets (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding shares and bonds etc of unconsolidated subsidiaries and associates (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding trade notes receivable discounted or transferred by endorsement (text) | CurrentYearInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |